Healthcare -
Biotechnology - NASDAQ - US
$ 46.95
2.44 %
$ 2.25 B
Market Cap
-22.57
P/E
Price Target
Average
15.73%
Revenue Forecast
Estimate
70.27%
EBIT
Estimate
--10.04%
Net Income
Estimate
48.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mirum Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for MIRM of $54.3 , with forecasts ranging from
a
low of
$39 to a high of $70 .
MIRM Lowest Price Target
Wall Street Target
39 USD
-16.93%
MIRM Average Price Target
Wall Street Target
54.3 USD
15.73%
MIRM Highest Price Target
Wall Street Target
70 USD
49.09%
REVENUE FORECAST
Revenue Forecast Chart MIRM
EBIT FORECAST
EBIT Forecast Chart MIRM
NET INCOME FORECAST
Net Income Chart MIRM